← Back to search

AMPHASTAR PHARMACEUTICALS INC

AMPH · NASDAQ

Pharmaceutical Preparation Manufacturing

Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin active pharmaceutical ingredient products. Most of the Company's finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

ESG Scores

Overall ESG
3.6
Environmental
2.4
Social
3.1
Governance
4.6

Gender Diversity

Female Directors0.3%
Female Executives0.11450381679389314%
CEO GenderMale

Market Data

Price$22.92+0.04 (+0.17%)
Market Cap$1.02B
P/E Ratio10.43
EPS$—
52W High$31.26
52W Low$17.03
Beta1.02